Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta

Clinical trial NCT00493116 · COMPLETED

Trial details

NCT number: NCT00493116
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2003-10-01
Primary completion: 2009-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.